New Drug-Eluting Stents May Be As Safe As Bare-Metal Types

Research also shows second-generation drug-eluding stents are safer than their predecessors when it comes to preventing thrombosis.

The first generation of drug-eluting stents (DES) that came along more than a decade ago were seen as promising tools in the treatment of coronary heart disease. But studies showed that DES raised the risk of stent thrombosis-blood clot formation at the site of the stent.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access